share_log
Reuters ·  2024/12/03 06:59

Applied Therapeutics: Following Issuance of a Complete Response Letter by FDA, Received Warning Letter Limited to at-007-1002 Study

应用治疗学:在FDA发出完整回应信后,收到针对at-007-1002研究的警告信

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发